Cell adhesion molecule 1

Cell adhesion molecule 1 is a protein that, in humans, is encoded by the CADM1 gene.

CADM1
Available structures PDB Ortholog search: PDBe RCSB List of PDB id codes 3BIN, 4H5S
Identifiers
Aliases	CADM1, BL2, IGSF4, IGSF4A, NECL2, Necl-2, RA175, ST17, SYNCAM, TSLC1, sTSLC-1, sgIGSF, synCAM1, cell adhesion molecule 1
External IDs	OMIM: 605686; MGI: 1889272; HomoloGene: 8641; GeneCards: CADM1; OMA:CADM1 - orthologs
Gene location (Human) Chr. Chromosome 11 (human) Band 11q23.3 Start 115,169,218 bp End 115,504,957 bp
Gene location (Mouse) Chr. Chromosome 9 (mouse) Band 9|9 A5.3 Start 47,530,173 bp End 47,858,115 bp
RNA expression pattern Bgee Human Mouse (ortholog) Top expressed in paraflocculus of cerebellum Pons periodontal fiber Achilles tendon caput epididymis corpus callosum visceral pleura islet of Langerhans spinal ganglia beta cell Top expressed in epithelium of lens otic placode ciliary body subiculum otic vesicle iris CA3 field saccule neural layer of retina Amygdala More reference expression data BioGPS More reference expression data
Gene ontology Molecular function PDZ domain binding protein homodimerization activity protein binding signaling receptor binding cell adhesion molecule binding Cellular component integral component of membrane membrane cell-cell junction synapse integral component of plasma membrane cell junction basolateral plasma membrane plasma membrane Biological process cell differentiation heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules activated T cell proliferation immune system process multicellular organism development cell adhesion spermatogenesis adherens junction organization T cell mediated cytotoxicity homophilic cell adhesion via plasma membrane adhesion molecules apoptotic process susceptibility to natural killer cell mediated cytotoxicity positive regulation of natural killer cell mediated cytotoxicity detection of stimulus cell recognition viral process Sources:Amigo / QuickGO
Orthologs Species Human Mouse Entrez 23705 54725 Ensembl ENSG00000182985 ENSMUSG00000032076 UniProt Q9BY67 Q8R5M8 RefSeq (mRNA) NM_001098517 NM_001301043 NM_001301044 NM_001301045 NM_014333 NM_001025600 NM_018770 NM_207675 NM_207676 NM_001310841 RefSeq (protein) NP_001091987 NP_001287972 NP_001287973 NP_001287974 NP_055148 NP_001020771 NP_001297770 NP_061240 NP_997558 NP_997559 Location (UCSC) Chr 11: 115.17 – 115.5 Mb Chr 9: 47.53 – 47.86 Mb PubMed search
Wikidata
View/Edit Human View/Edit Mouse

Interactions

Cell adhesion molecule 1 has been shown to interact with EPB41L3.

Association studies

Genome-wide association studies identified an association between body mass index and two loci near the CADM1 and CADM2 gene. Experimental results of another study showed that obese mice had an over expression of both CADM1 and CADM2 genes, and that loss of CADM1 protected mice from obesity, promoting a negative energy balance and weight loss. Furthermore, a 2019 GWAS study revealed an association between Anorexia nervosa and CADM1. In the brain, this genes mediate synaptic assembly, and mutations in CADM1 are also associated with Autistic spectrum disorder.

See also

• Cell adhesion molecule
• Nectin

Further reading

• Watabe K, Ito A, Koma YI, Kitamura Y (2004). "IGSF4: a new intercellular adhesion molecule that is called by three names, TSLC1, SgIGSF and SynCAM, by virtue of its diverse function". Histol. Histopathol. 18 (4): 1321–9. PMID 12973698.
• Kuramochi M, Fukuhara H, Nobukuni T, et al. (2001). "TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer" (PDF). Nat. Genet. 27 (4): 427–30. doi:10.1038/86934. hdl:2241/1028. PMID 11279526. S2CID 9773234.
• Masuda M, Yageta M, Fukuhara H, et al. (2002). "The tumor suppressor protein TSLC1 is involved in cell-cell adhesion". J. Biol. Chem. 277 (34): 31014–9. doi:10.1074/jbc.M203620200. PMID 12050160.
• Fukuhara H, Kuramochi M, Fukami T, et al. (2003). "Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer". Jpn. J. Cancer Res. 93 (6): 605–9. doi:10.1111/j.1349-7006.2002.tb01297.x. PMC 5927049. PMID 12079507.
• Allinen M, Peri L, Kujala S, et al. (2002). "Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: indications of TSLC1 promoter hypermethylation". Genes Chromosomes Cancer. 34 (4): 384–9. doi:10.1002/gcc.10079. PMID 12112527. S2CID 396701.
• Biederer T, Sara Y, Mozhayeva M, et al. (2002). "SynCAM, a synaptic adhesion molecule that drives synapse assembly". Science. 297 (5586): 1525–31. Bibcode:2002Sci...297.1525B. doi:10.1126/science.1072356. PMID 12202822. S2CID 14529914.
• Yageta M, Kuramochi M, Masuda M, et al. (2002). "Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer". Cancer Res. 62 (18): 5129–33. PMID 12234973.
• Jansen M, Fukushima N, Rosty C, et al. (2003). "Aberrant methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs". Cancer Biol. Ther. 1 (3): 293–6. doi:10.4161/cbt.84. PMID 12432281.
• Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. Bibcode:2002PNAS...9916899M. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
• Honda T, Tamura G, Waki T, et al. (2003). "Hypermethylation of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines". Jpn. J. Cancer Res. 93 (8): 857–60. doi:10.1111/j.1349-7006.2002.tb01329.x. PMC 5927103. PMID 12716461.
• Shingai T, Ikeda W, Kakunaga S, et al. (2003). "Implications of nectin-like molecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in cell-cell adhesion and transmembrane protein localization in epithelial cells". J. Biol. Chem. 278 (37): 35421–7. doi:10.1074/jbc.M305387200. PMID 12826663.
• Ito A, Okada M, Uchino K, et al. (2003). "Expression of the TSLC1 adhesion molecule in pulmonary epithelium and its down-regulation in pulmonary adenocarcinoma other than bronchioloalveolar carcinoma". Lab. Invest. 83 (8): 1175–83. doi:10.1097/01.LAB.0000081391.28136.80. PMID 12920246.
• Fukami T, Fukuhara H, Kuramochi M, et al. (2003). "Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines". Int. J. Cancer. 107 (1): 53–9. doi:10.1002/ijc.11348. PMID 12925956. S2CID 26363429.
• Uchino K, Ito A, Wakayama T, et al. (2003). "Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung". Cancer. 98 (5): 1002–7. doi:10.1002/cncr.11599. PMID 12942568. S2CID 35242800.
• Clark HF, Gurney AL, Abaya E, et al. (2003). "The Secreted Protein Discovery Initiative (SPDI), a Large-Scale Effort to Identify Novel Human Secreted and Transmembrane Proteins: A Bioinformatics Assessment". Genome Res. 13 (10): 2265–70. doi:10.1101/gr.1293003. PMC 403697. PMID 12975309.
• Fukuhara H, Masuda M, Yageta M, et al. (2003). "Association of a lung tumor suppressor TSLC1 with MPP3, a human homologue of Drosophila tumor suppressor Dlg". Oncogene. 22 (40): 6160–5. doi:10.1038/sj.onc.1206744. PMID 13679854.
• Ito T, Shimada Y, Hashimoto Y, et al. (2003). "Involvement of TSLC1 in progression of esophageal squamous cell carcinoma". Cancer Res. 63 (19): 6320–6. PMID 14559819.
• Mao X, Seidlitz E, Ghosh K, et al. (2004). "The cytoplasmic domain is critical to the tumor suppressor activity of TSLC1 in non-small cell lung cancer". Cancer Res. 63 (22): 7979–85. PMID 14633730.